Showing in vitro U87MG cell viability after treatment with CM from PTX-loaded MSCs. The kinetics of growth inhibition induced by serial 1:2 dilutions of CM from PTX-loaded MSCs on U87MG cells is compared with the growth inhibition of U87MG cells caused by PTX treatment at different concentrations (in the range of 1.56–200 ng/ml). The addition of CM induced a strong anti-proliferative effect in a dose-dependent fashion. Mean ± standard deviation are shown. (JPEG 293 kb
Figure S5. Comparison of distribution of anti-cancer effects for naïve MSC vs. naïve MSC used as con...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
The TQSS and EPSI drugs suppressed the viability of PC12 cells. (A) The viability of PC12 cells was ...
Showing assessment of PTX-induced nuclear changes in the brain cell populations. Immunostaining eith...
MBIC displayed synergistic effect with selected conventional drugs. A. shows isobolograms that link ...
Brivaracetam and lacosamide treatments displayed no cytotoxic effect on normal human fibroblast expo...
Additional file 2: Figure S1. Effects of different chemotherapeutic drugs on Jurkat cell proliferati...
Dose response curve and chemoprotection of leukemia cells by MSC. a-c Dose response curve showing pe...
Brivaracetam and lacosamide treatments induces accumulation of cells in G0/G1. a-b) Distribution of ...
Additional file 1: Figure S1. The effects of CDC7 inhibition on non-tumorigenic cells. A. 3T3 cells ...
Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...
MFX and CFX induced apoptosis is independent of p53 status. (i) Annexin-V assay ofHCT116 p53+/+ and ...
Evaluating the ability of pepstatin A (PepA) to block GAEL-induced cell death in EOC140 cells. a. EO...
Optimization of the treatment schedule potentiates MTA-cisplatin anticancer efficacy. Representative...
Figure S1. The effect of VCR or Epirubicin on RMS cells in vitro. (A) RMS cell lines were treated wi...
Figure S5. Comparison of distribution of anti-cancer effects for naïve MSC vs. naïve MSC used as con...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
The TQSS and EPSI drugs suppressed the viability of PC12 cells. (A) The viability of PC12 cells was ...
Showing assessment of PTX-induced nuclear changes in the brain cell populations. Immunostaining eith...
MBIC displayed synergistic effect with selected conventional drugs. A. shows isobolograms that link ...
Brivaracetam and lacosamide treatments displayed no cytotoxic effect on normal human fibroblast expo...
Additional file 2: Figure S1. Effects of different chemotherapeutic drugs on Jurkat cell proliferati...
Dose response curve and chemoprotection of leukemia cells by MSC. a-c Dose response curve showing pe...
Brivaracetam and lacosamide treatments induces accumulation of cells in G0/G1. a-b) Distribution of ...
Additional file 1: Figure S1. The effects of CDC7 inhibition on non-tumorigenic cells. A. 3T3 cells ...
Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...
MFX and CFX induced apoptosis is independent of p53 status. (i) Annexin-V assay ofHCT116 p53+/+ and ...
Evaluating the ability of pepstatin A (PepA) to block GAEL-induced cell death in EOC140 cells. a. EO...
Optimization of the treatment schedule potentiates MTA-cisplatin anticancer efficacy. Representative...
Figure S1. The effect of VCR or Epirubicin on RMS cells in vitro. (A) RMS cell lines were treated wi...
Figure S5. Comparison of distribution of anti-cancer effects for naïve MSC vs. naïve MSC used as con...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
The TQSS and EPSI drugs suppressed the viability of PC12 cells. (A) The viability of PC12 cells was ...